Skip to main content

Table 2 Characteristics of studies included in the systematic review of gastric cancer incidence in patients with intestinal metaplasia

From: Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review

First Author (year) [reference] Country Study Design Indication for Endoscopy Study follow up period Outcome Source Number of patients in cohort Male (%) Mean age (years) Follow-up (years) [mean/median] HP* positive (%)
Bleibel (2003) [39] United States of America Retrospective cohort NR* 1993–2012 Cancer registry 675 49 61 5.3 (mean) 18
De Vries (2010) [40] The Netherlands Prospective cohort NR* 2006–2007 Endoscopy 101 50 61 2.3 (mean) 18
González (2016) [38] Spain Retrospective cohort NR* 1995–2013 Pathology records, clinical records, endoscopy 467 56 53 12 (mean) 56
Horsley-Silva (2015) [26] United States of America Retrospective cohort Dyspepsia 2003–2004 NR* 200 50 68 4.1 (mean) 19
Kim (2008) [27] Korea Prospective cohort NR* 1992–1998 Endoscopy 515 88 45 10.2 (mean) 78
Li (2016) [18] United States of America Retrospective cohort NR* 1997–2013 Cancer registry, clinical records 4146 48 66 7.1 (median) 51
Reddy (2014) [19] United States of America Retrospective cohort NR* 2000–2011 Cancer registry 907 NR* 68 4.6 (median) NR*
Song (2015) [36] Sweden Retrospective cohort NR* 1979–2011 Endoscopy, Cancer registry, ONS* 11,530 55 66 7.9 (mean) NR*
Tava (2006) [12] Italy Retrospective cohort Dyspepsia 1989–1997 Endoscopy 259 51 60 3.9 (median) 27
  1. *NR Information not available, HP Helicobacter pylori, ONS Office for National Statistics